Organ-in-Cube: Next Generation Bionic Organ for Precision Medicine

Oncoimmunostics focuses on precision diagnostics and therapeutics by applying 3D bioprinting technology and AI to construct the patient-derived biomimetic disease microenvironment "Organ-in-Cube", which is the world’s first 3D-bioprinted pathologically bionic New Approach Methodology. “Organ-in-Cube” provides a fast, reliable pathway to personalized treatment selection while enabling standardized, high-throughput drug efficacy and toxicity evaluation. The product can also be used for preclinical drug efficacy evaluation, safety assessment, and pharmacokinetics for new drugs, which serves as a viable alternative to animal models and accelerates preclinical testing with accurate human-relevant data. “Organ-in-Cube” has a short manufacturing time, high biomimicry, high consistency and is superior to current organoid models and animal models.